AGEN three-lens brief
Evidence-based stock research on AGEN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · Negative free cash flow last quarterly (-$74.79M).
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- P/E of 2.3 — trading at a value multiple.
- Negative free cash flow last quarterly (-$74.79M).
AGEN closed at $6.89 (+0.44%) as of 2026-09-11. Market cap: $310.19M. P/E (trailing) 2.3. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; p/E of 2.3 — trading at a value multiple.. Concerns: negative free cash flow last quarterly (-$74.79M).. Last quarter: Revenue $34.50M, net income -$604.0K, free cash flow -$74.79M.
Why three lenses on AGEN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AGENacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AGEN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AGEN brief"></iframe>